A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China.

Dalin HeZhongquan SunJianming GuoZhigen ZhangYuxi ShanLulin MaHanzhong LiJie JinYiran HuangJiaquan XiaoQiang WeiDingwei Ye

Published in: Asia-Pacific journal of clinical oncology (2019)

Data from this study showed that around three-quarters of Chinese patients with mCRPC treated with docetaxel initiated treatment following first- or second-line hormonal therapy and no new safety signals were observed.

Keyphrases

squamous cell carcinoma
small cell lung cancer
locally advanced
electronic health record
stem cells
big data
machine learning
radiation therapy
double blind
replacement therapy
deep learning